Star Health & Allied Insurance Ltd Faces Technical Momentum Shift Amid Mixed Market Signals

Technical Trend Shift and Price Movement

As of 23 Feb 2026, Star Health & Allied Insurance’s share price closed at ₹454.10, down 1.12% from the previous close of ₹459.25. The stock’s intraday range was between ₹449.50 and ₹473.95, reflecting some volatility but an overall downward bias. The 52-week high stands at ₹533.90, while the 52-week low is ₹330.05, indicating a wide trading band over the past year.

The technical trend has shifted from mildly bullish to sideways, signalling a pause in upward momentum. This is corroborated by the Moving Averages on the daily chart, which remain mildly bullish, suggesting some short-term support. However, weekly and monthly indicators paint a more cautious picture.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator, a key momentum oscillator, is mildly bearish on both weekly and monthly timeframes. This suggests that the stock’s upward momentum is weakening over the medium to longer term. The MACD histogram has shown diminishing positive bars recently, indicating a potential loss of bullish momentum.

Meanwhile, the Relative Strength Index (RSI) on weekly and monthly charts shows no clear signal, hovering in neutral territory. This lack of directional RSI momentum implies that the stock is neither overbought nor oversold, consistent with the sideways trend.

Bollinger Bands and Volatility

Bollinger Bands on weekly and monthly charts are bearish, with the price gravitating towards the lower band. This suggests increased volatility and a potential downside risk if the stock breaks below support levels. The bands have widened slightly, indicating growing price fluctuations.

Other Technical Indicators

The Know Sure Thing (KST) oscillator is bearish on both weekly and monthly timeframes, reinforcing the view of weakening momentum. Conversely, the On-Balance Volume (OBV) indicator remains bullish on weekly and monthly charts, signalling that buying volume is still relatively strong despite price weakness. This divergence between price and volume could indicate accumulation by institutional investors or a potential base-building phase.

Dow Theory assessments are mixed: weekly readings are mildly bullish, while monthly readings are mildly bearish. This split suggests short-term optimism tempered by longer-term caution.

Relative Performance Versus Sensex

Examining Star Health’s returns relative to the Sensex provides further context. Over the past week, the stock declined by 2.94%, underperforming the Sensex’s modest 0.23% gain. However, over the past month, Star Health outperformed with a 4.4% return compared to the Sensex’s 0.77%. Year-to-date, the stock is marginally down by 0.2%, while the Sensex has fallen 2.82%, indicating relative resilience.

Over the last year, Star Health has delivered a robust 16.14% return, significantly outperforming the Sensex’s 9.35%. However, the three-year performance shows a stark contrast, with the stock down 19.68% against the Sensex’s 36.45% gain, highlighting challenges in sustaining long-term growth.

Mojo Score and Grade Downgrade

MarketsMOJO’s proprietary scoring system currently assigns Star Health a Mojo Score of 41.0, categorising it as a Sell. This represents a downgrade from the previous Hold rating on 20 Feb 2026. The downgrade reflects the deteriorating technical outlook and the mixed signals from key indicators. The Market Cap Grade remains low at 3, indicating limited market capitalisation strength relative to peers.

Investors should note that the downgrade is primarily driven by technical factors rather than fundamental changes, signalling caution in the near term but not necessarily a fundamental deterioration in business prospects.

Moving Averages and Short-Term Outlook

On the daily chart, moving averages remain mildly bullish, with the 20-day moving average slightly above the 50-day average. This suggests some short-term support and potential for a rebound if buying interest resumes. However, the proximity of the current price to these averages indicates limited upside momentum at present.

Given the sideways trend and mixed technical signals, traders may prefer to wait for a clear breakout above resistance levels near ₹474 or a breakdown below support near ₹449 before committing to new positions.

Investment Implications and Risk Considerations

Star Health & Allied Insurance’s technical profile suggests a period of consolidation with a cautious outlook. The bearish signals on weekly and monthly MACD, KST, and Bollinger Bands caution against aggressive buying, while the bullish OBV and mildly bullish daily moving averages hint at underlying support.

Investors should weigh these mixed signals carefully, considering the stock’s relative outperformance over the past year but underperformance over three years. The recent downgrade to Sell by MarketsMOJO further emphasises the need for prudence.

For those with existing exposure, monitoring volume trends and key technical levels will be critical to managing risk. New investors may prefer to observe price action for confirmation of trend direction before entering.

Conclusion: Navigating a Complex Technical Landscape

Star Health & Allied Insurance Company Ltd currently navigates a complex technical landscape marked by a shift to sideways momentum and mixed indicator signals. While short-term moving averages offer some bullish support, medium- and long-term oscillators and trend indicators suggest caution. The recent downgrade to a Sell rating by MarketsMOJO underscores the need for investors to adopt a measured approach.

Relative performance data shows the stock has outperformed the Sensex over the past year but lagged over three years, reflecting cyclical challenges in the insurance sector. Investors should monitor key technical levels closely and consider broader market conditions before making investment decisions.

Overall, Star Health’s technical parameters indicate a stock in consolidation, with potential for either a breakout or further correction depending on market sentiment and volume dynamics.

Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today